First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database

被引：0
|
作者：
Kenneth L. McCall
Bennett J. Doughty
Brian J. Piper
Heeral Naik
Seraphine Bange
Emily E. Leppien
机构：
[1] Binghamton University,Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences
[2] Geisinger Commonwealth School of Medicine,Department of Medical Education
[3] Geisinger Center for Pharmacy Innovation and Outcomes,School of Pharmacy and Pharmaceutical Sciences
[4] Binghamton University,Department of Mathematics and Statistics
[5] Binghamton University,undefined
来源：
International Journal of Clinical Pharmacy | 2024年 / 46卷
关键词：
Antipsychotics; Adverse drug events; Pharmacovigilance; Pharmacoepidemiology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：515 / 521
页数：6
相关论文
共 50 条
  • [21] Comparison of serious adverse reactions between thalidomide and lenalidomide: analysis in the French Pharmacovigilance database
    Pascale Olivier-Abbal
    Anne-Charlotte Teisseyre
    Jean-Louis Montastruc
    Medical Oncology, 2013, 30
  • [22] Reports of Symptoms Associated with Supraventricular Arrhythmias as a Serious Adverse Drug Reaction in the Spanish Pharmacovigilance Database
    Pueyo-Val, Javier
    Avedillo-Salas, Ana
    Berdun-Vinegra, Pablo
    Pueyo-Val, Olga Maria
    Fanlo-Villacampa, Ana
    Navarro-Peman, Cristina
    Lanuza-Gimenez, Francisco Javier
    Ioakeim-Skoufa, Ignatios
    Vicente-Romero, Jorge
    PHARMACEUTICALS, 2023, 16 (08)
  • [23] OPHTHALMOLOGICAL ADVERSE EVENTS UNDER JAK: CASE ANALYSIS OF THE EUROPEAN PHARMACOVIGILANCE DATABASE
    Hecquet, S.
    Rabier, M. B.
    Lepelley, M.
    Chouk, M.
    Verhoeven, F.
    Prati, C.
    Wendling, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 628 - 628
  • [24] Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database
    Zhao, Hui
    Li, Jun-Min
    Li, Zi-Ran
    Zhang, Qian
    Zhong, Ming-Kang
    Yan, Ming-Ming
    Qiu, Xiao-Yan
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [25] EXPLORING THE INCREASED SERIOUS ADVERSE EVENTS ASSOCIATED WITH INHALED TREPROSTINIL: AN FDA ADVERSE EVENT REPORTING SYSTEM DATABASE ANALYSIS
    Oli, Sharad
    Oli, Shital
    Niraula, Sristee
    Khanal, Resha
    CHEST, 2024, 166 (04) : 3535A - 3535A
  • [26] Bisphosphonate-Associated Psychiatric Adverse Events: A Signal from the Italian Pharmacovigilance Database
    Conforti, A.
    Corsano, S.
    Catalano, L.
    Magro, L.
    Donati, M.
    Leone, R.
    DRUG SAFETY, 2010, 33 (10) : 940 - 941
  • [27] Major adverse events associated with lipid reduction in inclisiran: a pharmacovigilance research of the FAERS database
    Huang, Zi-Tong
    Zhang, Wen-Hui
    Wang, Dong-Ze
    Zhang, Ya-Juan
    Duan, Yi-Bing
    He, Xin-Yang
    Gao, Yang-Xin
    Jia, Zhuo-Nan
    Xu, Qian
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [28] Psychiatric adverse events during aripiprazole associated to other antipsychotics: a retrospective study of cases reported within the French PharmacoVigilance database
    Kheloufi, F.
    Lepelley, M.
    Montastruc, F.
    Daveluy, A.
    Rouby, F.
    Drici, M. D.
    Mallaret, M.
    Micallef, J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 72 - 73
  • [29] Exploring the correlation between cardiovascular adverse events and antidepressant use: A retrospective pharmacovigilance analysis based on the FDA Adverse Event Reporting System database
    Wang, Zhanzhang
    Lu, Haoyang
    Li, Yuandan
    Huang, Shanqing
    Zhang, Ming
    Wen, Yuguan
    Shang, Dewei
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 367 : 96 - 108
  • [30] Adverse events associated with Atogepant: a FAERS-based pharmacovigilance analysis
    Zhang, Ying
    Sun, Shengzhu
    Wang, Yuming
    EXPERT OPINION ON DRUG SAFETY, 2024,
12345